ARCHIVES

FDA Hazleton Probe Finds Some Problems; Results Unaffected

This article is from The Cancer Letter archive.

Vol. 02 No. 17 | April 23, 1976

Download PDF Visit The Full Archive

Related Articles

In Brief: MSKCC Launches Molecular Oncology, Genomic Center

May 23, 2014

In Brief: Karen Antman And John Glick lead ASCO; ODAC to Meet June 7 On Tamoxifin Trial

May 27, 1994

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

April 27, 2012

Drug Effectiveness Weakens After Three Years, Study Says

May 27, 2011

Unclear Whether Insurance Will Cover AACR Losses

April 25, 2003

In Brief: Schmidt Asks NCI Grantees, Contractors To tell Him How They Waste Cancer Money

December 13, 1974